The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial.

What the trial testedas reported · 131 people · 2022

No range given

7.2×

Bigger than almost all for all-cause mortality

As reported

OR 7.241, no interval · the paper's word: All-cause mortality

No range given

18×

Bigger than almost all for all-cause mortality

As reported

OR 18.012, no interval · the paper's word: All-cause mortality

the abstract, start to end

… P = 0.003; ACE inhibitors: OR 7.241, P = 0.048, 95% CI 1.016-51.628; nitrates: OR 18.012, P = 0.011, 95% CI …

← favours treatmentfavours comparator →

could be chance

No interval given · direction only, strength unknown

All-cause mortality

OR 7.241

All-cause mortality

OR 18.012

Other cardiovascular drugsAll-cause mortality

Other cardiovascular drugs × all-cause mortalityhelps?one trial

unlikelylikely

0.50only evidence

1 / 4

2022

2023

2024

2025

this paperpooled itcites it